| Signalomics for molecular tumor boards and precision oncology of breast and gynecological cancers | Molecular systems biology |  | | 2025 | 75 | 57 |
|
| Loss of the conserved switch III region in a G protein leads to severe pediatric encephalopathy | Science signaling |  | | 2025 | 29 | 0 |
|
| Clinical-molecular profiling of atypical GNAO1 patients : Novel pathogenic variants, unusual manifestations, and severe molecular dysfunction | Genes & diseases | | | 2025 | 50 | 47 |
|
| Success and Controversy of Natural Products as Therapeutic Modulators of Wnt Signaling and Its Interplay with Oxidative Stress : Comprehensive Review Across Compound Classes and Experimental Systems | Antioxidants | | | 2025 | 54 | 559 |
|
| Syndecan-2 positively regulates Wnt/β-catenin signaling in breast cancer cells | International journal of biochemistry & cell biology | | | 2025 | 48 | 0 |
|
| Atypical GNAO1 variants in severe childhood speech disorders: clinical, genetic, and molecular insights | Molecular autism | | | 2025 | 26 | 46 |
|
| Integration of Wnt-inhibitory activity and structural novelty scoring results to uncover novel bioactive natural products : new Bicyclo[3.3.1]non-3-ene-2,9-diones from the leaves of Hymenocardia punctata | Frontiers in chemistry | | | 2024 | 135 | 139 |
|
| Germline mutations in a G protein identify signaling cross-talk in T cells | Science | | | 2024 | 193 | 0 |
|
| Neomorphic Gαo mutations gain interaction with Ric8 proteins in GNAO1 encephalopathies | The Journal of clinical investigation | | | 2024 | 107 | 130 |
|
| Zinc for GNAO1 encephalopathy : preclinical profiling and a clinical case | Med | | | 2024 | 140 | 397 |
|
| Challenging Reported Frizzled-Targeting Compounds in Selective Assays Reveals Lack of Functional Inhibition and Claimed Profiles | ACS pharmacology & translational science | | | 2024 | 206 | 138 |
|
| Chemical and Biological Characterization of Metabolites from Silene viridiflora Using Mass Spectrometric and Cell-Based Assays | Biomolecules | | | 2024 | 105 | 465 |
|
| Clinical and Molecular Profiling in GNAO1 Permits Phenotype–Genotype Correlation | Movement disorders | | | 2024 | 108 | 256 |
|
| GNAO1 Mutations Affecting the N‐Terminal α‐Helix of Gαo Lead to Parkinsonism | Movement disorders | | | 2024 | 124 | 316 |
|
| Cis-regulatory polymorphism at fiz ecdysone oxidase contributes to polygenic evolutionary response to malnutrition in Drosophila | PLOS genetics | | | 2024 | 80 | 257 |
|
| Clinical Cases and the Molecular Profiling of a Novel Childhood Encephalopathy-Causing GNAO1 Mutation P170R | Cells | | | 2023 | 125 | 106 |
|
| Wnt-Independent SARS-CoV-2 Infection in Pulmonary Epithelial Cells | Microbiology spectrum | | | 2023 | 195 | 260 |
|
| Shallow- and deep-water Ophiura species produce a panel of chlorin compounds with potent photodynamic anticancer activities | Antioxidants | | | 2023 | 256 | 110 |
|
| Clofazimine: a journey of a drug | Biomedicine & pharmacotherapy | | | 2023 | 109 | 504 |
|
| In-depth molecular profiling of an intronic GNAO1 mutant as the basis for personalized high-throughput drug screening | Med | | | 2023 | 145 | 1 |
|
| Pediatric GNAO1 encephalopathies: from molecular etiology of the disease to drug discovery | Neural Regeneration Research | | | 2023 | 116 | 203 |
|
| Improved approaches to channel capacity estimation discover compromised GPCR signaling in diverse cancer cells | iScience | | | 2023 | 100 | 116 |
|
| Gαi2-induced conductin/axin2 condensates inhibit Wnt/β-catenin signaling and suppress cancer growth | Nature communications | | | 2022 | 387 | 335 |
|
| Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: from thienopyrimidine to quinazoline inhibitors | Frontiers in pharmacology | | | 2022 | 222 | 299 |
|
| Chemoenzymatic synthesis of complex phenylpropanoid derivatives by the Botrytis cinerea secretome and evaluation of their wnt inhibition activity | Frontiers in plant science | | | 2022 | 317 | 232 |
|
| Chemoenzymatic synthesis of original stilbene dimers possessing wnt inhibition activity in triple-negative breast cancer cells using the enzymatic secretome of Botrytis cinerea pers | Frontiers in chemistry | | | 2022 | 247 | 266 |
|
| Restoration of the GTPase activity and cellular interactions of Gαo mutants by Zn2+ in GNAO1 encephalopathy models | Science advances | | | 2022 | 217 | 214 |
|
| Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutation | Acta neuropathologica communications | | | 2022 | 287 | 171 |
|
| Mining natural compounds to target WNT signaling: land and sea tales | Pharmacology of the WNT signaling system | | | 2021 | 231 | 1 |
|
| Pediatric encephalopathy: cinical, biochemical and cellular insights into the role of Gln52 of GNAO1 and GNAI1 for the dominant disease | Cells | | | 2021 | 414 | 280 |
|
| A cytotoxic porphyrin from North Pacific brittle star Ophiura sarsii | Marine Drugs | | | 2021 | 504 | 255 |
|
| Optimization of the clofazimine structure leads to a highly water-soluble C3-aminopyridinyl riminophenazine endowed with improved anti-Wnt and anti-cancer activity in vitro and in vivo | European Journal of Medicinal Chemistry | | | 2021 | 295 | 232 |
|
| Unlocking the Wnt pathway : therapeutic potential of selective targeting FZD7 in cancer | Drug discovery today | | | 2021 | 555 | 556 |
|
| Short stature and combined immunodeficiency associated with mutations in RGS10 | Science Signaling | | | 2021 | 241 | 0 |
|
| Isolation and identification of isocoumarin derivatives with specific inhibitory activity against wnt pathway and metabolome characterization of lasiodiplodia venezuelensis | Frontiers in Chemistry | | | 2021 | 383 | 1,113 |
|
| Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells | Communications Biology | | | 2021 | 354 | 252 |
|
| Generation of stilbene antimicrobials against multiresistant strains of Staphylococcus aureus through biotransformation by the enzymatic secretome of Botrytis cinerea | Journal of Natural Products | | | 2020 | 372 | 618 |
|
| Beyond TNBC: repositioning of clofazimine against a broad range of Wnt-dependent cancers | Frontiers in Oncology | | | 2020 | 347 | 315 |
|
| Targeting the Wnt signalling pathway in cancer: prospects and perils | Swiss Medical Weekly | | | 2019 | 604 | 395 |
|
| Chemo-diversification of plant extracts using a generic bromination reaction and monitoring by metabolite profiling | ACS Combinational Science | | | 2019 | 418 | 0 |
|
| A high-throughput assay pipeline for specific targeting of frizzled GPCRs in cancer | Methods in Cell Biology |  | | 2019 | 372 | 0 |
|
| Towards the first targeted therapy for triple-negative breast cancer: Repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor | Cancer Letters | | | 2019 | 1,156 | 586 |
|
| Dramatic dysbalancing of the Wnt pathway in breast cancers | Scientific Reports | | | 2018 | 323 | 189 |
|
| High capacity in G protein-coupled receptor signaling | Nature Communications | | | 2018 | 399 | 231 |
|
| Tannins from Syzygium guineense suppress Wnt signaling and proliferation of Wnt-dependent tumors through a direct effect on secreted Wnts | Cancer Letters | | | 2018 | 347 | 921 |
|
| High-throughput targeted screening in triple-negative breast cancer cells identifies Wnt-inhibiting activities in Pacific brittle stars | Scientific Reports | | | 2017 | 407 | 218 |
|
| Golgi-Resident Gαo Promotes Protrusive Membrane Dynamics | Cell | | | 2017 | 489 | 503 |
|
| Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition | BioFactors | | | 2017 | 446 | 849 |
|
| Inhibition of Wnt signalling and breast tumour growth by the multi-purpose drug suramin through suppression of heterotrimeric G proteins and Wnt endocytosis | Biochemical Journal | | | 2016 | 412 | 562 |
|
| A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers | Cancers | | | 2016 | 425 | 490 |
|
